SCHEMBL13087948

SCHEMBL13087948

CCS(=O)(=O)N1CCC(Oc2cc(-c3ccncc3)cc3ccncc23)CC1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 10/20 0.61
CHUK O15111 7/20 0.60
NAMPT P43490 3/20 0.43
CYP17A1 P05093 2/20 0.41
CYP21A2 P08686 2/20 0.41
CYP11B1 P15538 2/20 0.41
CYP3A4 P08684 1/20 0.39
CYP19A1 P11511 1/20 0.39
MMP13 P45452 2/20 0.37
NAAA Q02083 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
MMP14 P50281 1/20 0.36
AKT1 P31749 1/20 0.36
ROCK1 Q13464 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13087926 0.94 IKBKB (0.69) IKBKBCHUKNAMPTNAAAALDH1A1
SCHEMBL13087829 0.91 IKBKB (0.62) IKBKBCHUKNAMPTCYP11B1ALDH1A1
SCHEMBL13088172 0.90 IKBKB (0.49) IKBKBCHUKCYP17A1CYP21A2CYP11B1
SCHEMBL13087953 0.90 IKBKB (0.58) IKBKBCHUKNAMPTCYP17A1CYP21A2
SCHEMBL13088195 0.90 IKBKB (0.56) IKBKBCHUKNAMPTCYP17A1CYP21A2
SCHEMBL13087678 0.90 IKBKB (0.60) IKBKBCHUKNAMPTALDH1A1TSHR
SCHEMBL13087946 0.89 IKBKB (0.55) IKBKBCHUKNAMPTALDH1A1CYP2C9
SCHEMBL13087957 0.88 IKBKB (0.47) IKBKBCHUKNAMPTCYP17A1CYP21A2
SCHEMBL13087665 0.88 IKBKB (0.59) IKBKBCHUKNAMPTNAAAALDH1A1
SCHEMBL13087952 0.88 IKBKB (0.56) IKBKBCHUKNAMPTNAAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof RELA, NFKBIA, NFKB2 IKBKB 7/4885CHUK 17/4885NAMPT 2852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.